Last updated on February 2020

Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients


Brief description of study

The purpose of this study is to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of M254 after administration of a single ascending dose and repeat doses in healthy volunteers and immune thrombocytopenic purpura (ITP) patients. The pharmacodynamics of the drug will be measured as platelet response in patients with ITP.

Detailed Study Description

The Part A of the study is currently not accepting healthy volunteers as the recruitment for the part A has completed.

Clinical Study Identifier: NCT03866577

Find a site near you

Start Over

Momenta Investigational Site

San Giovanni Rotondo, Italy
  Connect »